Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. [electronic resource]
Producer: 20110207Description: 31-8 p. digitalISSN:- 2046-4924
- Acute Coronary Syndrome -- drug therapy
- Angioplasty, Balloon, Coronary -- adverse effects
- Clopidogrel
- Cost-Benefit Analysis
- Humans
- Models, Economic
- Piperazines -- adverse effects
- Platelet Aggregation Inhibitors -- economics
- Prasugrel Hydrochloride
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Quality of Life
- Quality-Adjusted Life Years
- Risk Assessment
- Thiophenes -- adverse effects
- Ticlopidine -- adverse effects
- United Kingdom
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.